The Board
![Alan Raymond](https://aeliusbiotech.co.uk/wp-content/uploads/2024/03/Alan-Raymond-015-3.jpg)
Experienced senior executive and chair in the healthcare sector with roles at Merck, Reckitt & Colman, Aesica Pharmaceuticals and others
Alan Raymond
Chair
![Dr Peter Chater](https://aeliusbiotech.co.uk/wp-content/uploads/2024/03/Peter-Chater-010.jpg)
Gastrointestinal physiologist and biomedical scientist by training, co-founder of Aelius, MBA
Dr Peter Chater
CEO
![Professor Jeff Pearson](https://aeliusbiotech.co.uk/wp-content/uploads/2024/03/Jeff-Pearson-022-1.jpg)
Professor of Molecular Physiology with expertise in gatrointestinal physiology, mucus, pepsin and gastroeosophageal reflux
Professor Jeff Pearson
CSO
![Dr Richard Weaver](https://aeliusbiotech.co.uk/wp-content/uploads/2024/03/Richard-Weaver-042-1.jpg)
DMPK scientist and entrepreneur, Richard founded XenoGesis in 2011. Following a successful exit he joined Aelius as a Director
Dr Richard Weaver
Non-executive Director
![Dr Matthew Wilcox](https://aeliusbiotech.co.uk/wp-content/uploads/2024/03/Matt-Wilcox-002-1.jpg)
Human physiologist and Biotechnologist, co-founder of Aelius Biotech with expertise in human trial design and gut modelling
Dr Matthew Wilcox
COO
![Geoff Maclaughlan](https://aeliusbiotech.co.uk/wp-content/uploads/2024/02/george_aelius.png)
Experienced senior financial director
Geoff Maclaughlan
CFO